Osler Diagnostics develops the Osler Origin, a portable diagnostic platform designed to deliver lab-quality testing anywhere with high performance, rapid, low-cost, and easy-to-use operation. The Osler Origin aims to offer a wide portfolio of high-performance diagnostic tests across all major healthcare settings globally, addressing limitations of existing portable solutions. The company plans to advance the Osler Origin through regulatory activities and toward market launch. Osler was formed out of the University of Oxford in 2017 and is headquartered in Oxford, UK. The company employs more than 100 staff and is backed by leading investors. Recent financing will support its regulatory pathway and commercialization efforts.

Total raised

$85M

Funding rounds

1

Latest round

Series C

Latest activity

Nov 2022